Petition to FDA: Withdraw Aricept 23mg Immediately

Public Citzen petitioned  FDA Commissioner to immediately removal from market Pfizer’s Alzheimer’s drug, Aricept  23 mg dose, because of serious safety hazards and failure to demonstrate efficacy. The petition also urges FDA to add a label warning on Aricept and generic donepezil (5 mg and 10 mg) stating: "Use of 20 mg per day is counter indicated."

Continue reading →